Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.
Ophthonix is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gamma Medica-Ideas (GM-I), Inc is a Northridge, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Prizm Medical is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anachem Corp is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.